A Comparative Feasibility Analysis of Biotechnology Infrastructure Projects: Evaluating Financing Systems (B.O.O.T) vs. (B.O.T)

Abstract

This study conducts a comparative feasibility analysis of biotechnology infrastructure projects under two financing systems: Build-Operate-Transfer (B.O.T) and Build-Own-Operate-Transfer (B.O.O.T). The research evaluates the economic and operational implications of these financing methods for both stakeholders—government entities and private sector investors. Investment and operational costs, along with projected revenue streams, were estimated for both financing scenarios. Financial ratios were extracted to assess the viability of the projects under each system. Evaluation criteria included both descriptive and quantitative metrics, with relative weights assigned to account for their varying significance and impact on investment decisions. The analysis revealed that the B.O.T system is more favorable for biotechnology infrastructure projects, achieving a score of 90% compared to 60% for the B.O.O.T system when weighted criteria were applied. The B.O.T system demonstrated greater economic feasibility for private sector investors while simultaneously aligning with government objectives to stimulate innovation and infrastructure development. Based on these findings, the study recommends prioritizing the B.O.T financing model for biotechnology projects, as it offers a balanced and sustainable approach to meeting the needs of both public and private stakeholders. This research provides a framework for financing decisions that could accelerate the growth and commercialization of biotechnology ventures in emerging markets.